Qualigen Therapeutics Stock Set to Reverse Split on Tuesday, November 5th (NASDAQ:QLGN)

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares are scheduled to reverse split on Tuesday, November 5th. The 1-50 reverse split was announced on Friday, November 1st. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, November 4th.

Qualigen Therapeutics Stock Down 0.2 %

Shares of QLGN stock traded down $0.00 during mid-day trading on Friday, hitting $0.10. The company’s stock had a trading volume of 2,685,487 shares, compared to its average volume of 4,660,945. Qualigen Therapeutics has a 52-week low of $0.08 and a 52-week high of $0.78. The business has a 50-day moving average price of $0.16 and a 200 day moving average price of $0.22.

Qualigen Therapeutics (NASDAQ:QLGN) last issued its earnings results on Wednesday, August 14th. The company reported ($0.20) earnings per share for the quarter.

About Qualigen Therapeutics

Qualigen Therapeutics, Inc, a biotechnology company, focuses on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a patent-protected rapid, onsite immunoassay testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, an oligonucleotide-based drug candidate to treat various nucleolin-expressing cancers, including liquid and solid tumors; QN-165, a drug candidate for the potential broad-spectrum treatment of infectious diseases, such as COVID-19; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and selective target antigen removal system, a therapeutic device to remove circulating tumor cells, viruses, inflammation factors, and immune checkpoints.